Perrigo launches store brand equivalent for Zegerid OTC

DUBLIN - Perrigo announced Monday that the U.S. Food and Drug Administration has approved the company's ANDA for omeprazole and sodium bicarbonate capsules, 20mg/1100mg.  This approval will initiate the first store brand launch of an equivalent product to Zegerid OTC capsules.

Shipments to retail customers have already commenced.

Zegerid OTC is indicated for the treatment of frequent heartburn. National brand sales for the twelve months ending June 2016 were $27 million.